Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Avatar

Chemotherapy vs. Chemo Free in Indolent Non-Hodgkin Lymphoma - Can We Improve Outcomes With Emerging Agents?

By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Nathan H. Fowler
October 2019
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
UChicago Medicine Comprehensive Cancer Center

UChicago Annual Updates from ASH 2019

Fri, Feb 28, 2020
8th ESO-SIOP Europe Masterclass in Paediatric Oncology

8th ESO-SIOP Europe Masterclass in Paediatric Oncology

Sat, Jun 6, 2020
Cleveland Clinic's 20th Annual ASH Review

Cleveland Clinic's 20th Annual ASH Review

Wed, Jan 22, 2020
Indy Hematology Review

17th Indy Hematology Review

Sat, Mar 21, 2020
UNMC 2020 Lymphoma Study Group & Hematology Highlights: A Post ASH Review

2020 Lymphoma Study Group & Hematology Highlights: A Post ASH Review

Fri, Feb 7, 2020
12:53
KU Hematology & Medical Oncology Review 2019

ASCO 2019 Non Hodgkin Lymphoma Update : Polatuzumab Vedotin for R/R DLBC...

Feat. M. Hoffmann
19:49
2018 Pan Pacific Lymphoma Conference

Cutaneous T-cell Lymphoma: Management of Transformed Mycosis Fungoides a...

Feat. Y. Kim
24:51
KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH December 2018- Lymphoma - Efficacy and Safety from ZUMA 1, JULIET an...

Feat. F. Locke
06:12
Indy Hematology Review

New Approaches in DLBCL

Feat. J. Leonard
30:08
City of Hope

Advances in Therapy in Cutaneous T Cell Lymphoma

Feat. C. Querfeld
15:41
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

PI3Ki's in Indolent Lymphoma: Overview of Approved Drugs, Trial Based Da...

Feat. A. Zelenetz
08:39
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Next Questions in Hodgkin Lymphoma: Brentuximab Vedotin/PD-1+AVD as Fron...

Feat. S. Ansell
16:04
Xth Eurasian Hematology-Oncology Congress

St-Petersburg Hematological Centre Experience on the Use of BMT in Relap...

Feat. N. Mikhailova
10:24
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Double-Hit Lymphoma Diagnosis, Initial and Relapsed/Refractory Treatment...

Feat. K. Dunleavy
07:27
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Plasmablastic Lymphoma: Survival Analysis of a SEER Database (2010-2016)...

Feat. J. Florindez
15:29
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

How I Treat Early Stage Hodgkin Lymphoma: Early Stage Favorable Chemo vs...

Feat. A. Evens
12:54
Craig Portell

Untreated Follicular Lymphoma - Treatment Options for Patients with Earl...

13:27
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Treatment of Primary CNS Lymphoma: Upfront Regimen, Surgery, Treatment o...

Feat. C. Grommes
14:46
Indy Hematology Review

Treatment of Follicular Lymphoma and Other Indolent Lymphomas: Is Target...

Feat. B. Cheson
25:14
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Waldenstrom Macroglobulinemia Treatment Options: Alkylators Are Recommen...

Feat. J. Richter
15:50
Indy Hematology Review

Treatment Algorithm for DLBCL

Feat. J. Leonard
13:07
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Advanced Stage Hodgkin Lymphoma: New EvIdence in Induction, Treatment In...

Feat. P. Zinzani
22:47
UChicago CAR T-Cell Symposium 2019

Patient Selection for CAR T-Cell Therapy: Therapeutic Benefits, Discussi...

Feat. M. Leukam
20:51
Carla Casulo

Prognostic Markers in Follicular Lymphoma, FLIPI Score and Results of PR...

10:42
Paolo Strati

Clinical and Radiological Correlates of Neurotoxicity after Standard of ...